Author | Daniel P. Petrylak, MD | OncLive

Author | Daniel P. Petrylak, MD

Articles

Dr. Petrylak on the Results of the EV-103 Trial in Bladder Cancer

May 01, 2020

Video

Daniel P. Petrylak, MD, professor of medicine and urology, co-leader, Cancer Signaling Networks, Yale Cancer Center, and 2017 Giant of Cancer Care® in Genitourinary Cancers, discusses the results of the phase 1b/2 EV-103 trial in bladder cancer.

Dr. Petrylak on Available Treatment Options in Metastatic Bladder Cancer

March 13, 2020

Video

Daniel P. Petrylak, MD, discusses available treatment options in metastatic bladder cancer.

Dr. Petrylak on Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Carcinoma

June 04, 2019

Video

Daniel P. Petrylak, MD, professor of medicine and urology at Yale Cancer Center, 2017 Giant of Cancer Care in Genitourinary Cancers, discusses the phase II EV-201 trial of enfortumab vedotin in patients with locally advanced or metastatic urothelial cancer who were previously treated with platinum-based chemotherapy or a PD-1/PD-L1 checkpoint inhibitor.

Dr. Petrylak on Combinations with Pembrolizumab in Urothelial Carcinoma

July 13, 2017

Video

Daniel P. Petrylak, MD, professor of Medicine and Urology, Yale Cancer Center, discusses combinations with pembrolizumab (Keytruda) for patients with urothelial carcinoma.

x